BPG致力于知识发现和传播
预出版
2024/12/17 1:45:49 | Browse: 1 | 下载: 0
Publication Name 世界华人消化杂志
手稿编号 40077
手稿来源省、自治区或特别行政区 福建省
专业类型 消化肿瘤学
手稿栏目类型 述评
文章标题 脂肪肉瘤免疫治疗的现状与前景: 从基础研究到临床实践
手稿来源 约稿
所有作者列表 庄奥博, 席哲, 成映雪, 张辰赫, 李文岗
基金项目及其编号
基金项目名称 基金编号
福建省公益类科研院所基本科研专项 2023R1037
通讯作者 李文岗, 博士, 教授, 主任医师, 361102, 福建省厦门市翔安区翔安东路2000号, 厦门大学翔安医院肝胆胰血管外科. lwg11861@163.com
关键词 脂肪肉瘤; 免疫治疗; 肿瘤免疫微环境; 免疫逃逸; 免疫检查点抑制剂; 个体化治疗
核心内容提要 本文全面概述了脂肪肉瘤免疫治疗的最新进展, 深入探讨了其独特的肿瘤免疫微环境、免疫逃逸机制及分子亚型. 文章重点介绍了免疫检查点抑制剂、联合治疗策略和过继性细胞疗法等新兴治疗手段, 分析了免疫治疗面临的挑战和个体化精准医学在提升脂肪肉瘤治疗效果中的潜力, 为改善患者预后提供了新的视角.
引文著录 庄奥博, 席哲, 成映雪, 张辰赫, 李文岗. 脂肪肉瘤免疫治疗的现状与前景: 从基础研究到临床实践. 世界华人消化杂志 2024
Received
2024-10-08 05:54
Peer-Review Started
2024-10-08 11:23
To Make the First Decision
Return for Revision
2024-10-31 00:25
修回稿
2024-11-06 04:08
Second Decision
2024-11-28 00:49
期刊总编辑接受
公司总编辑接受
2024-12-17 01:45
预出版
2024-12-17 01:45
缴纳版面费
Edit the Manuscript by Language Editor
排版
ISSN 1009-3079 (print) and 2219-2859 (online)
开放获取 This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权 © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址 http://www.wjgnet.com
Assistant Editor 吴云晓健
Science Editor 张砚梁
评议人编号 03656466, 03725062, 03656392, and 03656531
Editorial Director
Journal Chief Editor
Company Chief Editor 闫佳萍
Language Editor
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma